Well Joel & Co- 12c at announcement of redomicile.- 4.1c at...

Well Joel & Co

- 12c at announcement of redomicile.
- 4.1c at leaving the ASX.

Sure, other factors may have been at play, but that's the bar set. Currently listing at 100-1 is $2.65, market cap around $65m AUD or 42m USD. Well in the duldrums of the NDQ. Can he drum up enough interest?

Other similar fields

https://atai.life/programs/ - 184m market cap, 3 phase 1 and 2 phase 2 and some equity interest.

https://compasspathways.com/ - 350m market cap, phase 3 trials for PTSD and TRD (this one confuses me because i thought we had this already)

This one is the most relevent

https://mindmed.co/clinical-digital-trials/ - Mind Med - Multiple things happening but looks like only a couple of actual things in the pipeline. Namely anxiety and ADHD phase 2 trials are currently finishing up (not sure when results are due. Market Cap $100m. Total book value around 95m, but their cash balance is very high compared to IHL at 100m+. Obviously this is going to be a contentious point for some investors.